International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)
Russia
· Delayed Price · Currency is RUB 672.00
-1.50 (-0.22%)
At close: Jul 8, 2022
MOEX:GEMA Ratios and Metrics
Market cap in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,033 | 10,033 | 10,033 | 10,033 | 14,915 | 10,302 | Upgrade
|
| Market Cap Growth | - | - | - | -32.73% | 44.78% | -9.39% | Upgrade
|
| Enterprise Value | 10,029 | 10,045 | 10,171 | 10,076 | 14,939 | 10,314 | Upgrade
|
| Last Close Price | 672.00 | 672.00 | 672.00 | 672.00 | 950.69 | 580.21 | Upgrade
|
| PE Ratio | 66.35 | 66.35 | 79.77 | 102.20 | 98.94 | 83.91 | Upgrade
|
| PS Ratio | 27.29 | 28.78 | 35.39 | 39.40 | 56.10 | 42.46 | Upgrade
|
| PB Ratio | 32.40 | 33.02 | 22.76 | 67.45 | 66.00 | 49.06 | Upgrade
|
| P/TBV Ratio | 42.86 | 44.55 | 28.18 | 172.94 | 74.92 | 58.09 | Upgrade
|
| P/FCF Ratio | 40.74 | 42.33 | 47.87 | 43.28 | 62.19 | 77.89 | Upgrade
|
| P/OCF Ratio | 39.20 | 40.52 | 44.84 | 41.61 | 61.00 | 76.47 | Upgrade
|
| EV/Sales Ratio | 27.28 | 28.82 | 35.88 | 39.56 | 56.19 | 42.51 | Upgrade
|
| EV/EBITDA Ratio | 51.02 | 53.72 | 64.52 | 70.75 | 105.17 | 69.54 | Upgrade
|
| EV/EBIT Ratio | 55.32 | 56.39 | 68.10 | 72.70 | 108.33 | 72.70 | Upgrade
|
| EV/FCF Ratio | 40.72 | 42.38 | 48.53 | 43.46 | 62.29 | 77.98 | Upgrade
|
| Debt / Equity Ratio | 0.87 | 0.90 | 0.59 | 1.76 | 0.24 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 1.37 | 1.42 | 1.62 | 1.80 | 0.39 | 0.39 | Upgrade
|
| Debt / FCF Ratio | 1.10 | 1.15 | 1.24 | 1.13 | 0.23 | 0.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.17 | 0.14 | 1.19 | 0.08 | 0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.36 | -0.28 | 0.41 | 1.24 | 0.13 | 0.23 | Upgrade
|
| Net Debt / FCF Ratio | -0.28 | -0.22 | 0.31 | 0.76 | 0.08 | 0.26 | Upgrade
|
| Asset Turnover | 0.30 | 0.28 | 0.26 | 0.32 | 0.39 | 0.40 | Upgrade
|
| Inventory Turnover | 8.74 | 7.60 | 9.88 | 10.81 | 15.68 | 10.19 | Upgrade
|
| Quick Ratio | 2.18 | 1.84 | 1.24 | 0.83 | 3.53 | 0.97 | Upgrade
|
| Current Ratio | 2.25 | 1.92 | 1.36 | 0.90 | 3.58 | 1.02 | Upgrade
|
| Return on Equity (ROE) | 41.34% | 40.61% | 42.67% | 52.39% | 59.26% | 60.46% | Upgrade
|
| Return on Assets (ROA) | 9.13% | 8.86% | 8.63% | 10.95% | 12.77% | 14.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 75.55% | 47.09% | 35.99% | 48.62% | 56.41% | 64.81% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.10% | 17.00% | 13.60% | 18.90% | 26.00% | 28.90% | Upgrade
|
| Earnings Yield | 1.51% | 1.51% | 1.25% | 0.98% | 0.87% | 1.19% | Upgrade
|
| FCF Yield | 2.45% | 2.36% | 2.09% | 2.31% | 1.61% | 1.28% | Upgrade
|
| Dividend Yield | 1.29% | 1.15% | 0.95% | 1.19% | 0.91% | - | Upgrade
|
| Payout Ratio | 99.74% | 101.44% | 97.58% | 143.69% | 116.27% | 69.31% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | - | - | 0.00% | -0.00% | -11.11% | Upgrade
|
| Total Shareholder Return | 1.34% | 1.15% | 0.95% | 1.20% | 0.91% | -11.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.